BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23107284)

  • 1. NT-proBNP independently predicts long term mortality after acute exacerbation of COPD - a prospective cohort study.
    Høiseth AD; Omland T; Hagve TA; Brekke PH; Søyseth V
    Respir Res; 2012 Oct; 13(1):97. PubMed ID: 23107284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD.
    Li H; Zeng Z; Cheng J; Hu G; Li Y; Wei L; Zhou Y; Ran P
    Int J Chron Obstruct Pulmon Dis; 2020; 15():57-67. PubMed ID: 32021144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
    Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
    Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between N-terminal probrainnatriuretic peptide and prognosis of acute exacerbations of chronic obstructive pulmonary disease].
    Zhao CL; Zhang QR; Huang JW; Zhang L; Zhou M
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Feb; 41(2):95-99. PubMed ID: 29429214
    [No Abstract]   [Full Text] [Related]  

  • 5. N-Terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) as a Diagnostic Biomarker of Left Ventricular Systolic Dysfunction in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
    Andrijevic I; Milutinov S; Lozanov Crvenkovic Z; Matijasevic J; Andrijevic A; Kovacevic T; Bokan D; Zaric B
    Lung; 2018 Oct; 196(5):583-590. PubMed ID: 29951921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized evaluation of lung congestion during COPD exacerbation better identifies patients at risk of dying.
    Høiseth AD; Omland T; Karlsson BD; Brekke PH; Søyseth V
    Int J Chron Obstruct Pulmon Dis; 2013; 8():621-9. PubMed ID: 24353412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NT-pro BNP in AECOPD-PH: old biomarker, new insights-based on a large retrospective case-controlled study.
    Tian F; Song W; Wang L; Zeng Q; Zhao Z; Feng N; Fan J; Wang Y; Wang J; Ma X
    Respir Res; 2021 Dec; 22(1):321. PubMed ID: 34961527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
    Labaki WW; Xia M; Murray S; Curtis JL; Barr RG; Bhatt SP; Bleecker ER; Hansel NN; Cooper CB; Dransfield MT; Wells JM; Hoffman EA; Kanner RE; Paine R; Ortega VE; Peters SP; Krishnan JA; Bowler RP; Couper DJ; Woodruff PG; Martinez FJ; Martinez CH; Han MK
    Respir Med; 2018 Jul; 140():87-93. PubMed ID: 29957287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of plasma N-terminal brain natriuretic pro-peptide in diagnosing elderly patients with acute exacerbation of COPD concurrent with left heart failure.
    Guo X; Nie H; Chen Q; Chen S; Deng N; Li R; Ding X; Hu S; Wang A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2931-2940. PubMed ID: 30275691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD.
    Chang CL; Robinson SC; Mills GD; Sullivan GD; Karalus NC; McLachlan JD; Hancox RJ
    Thorax; 2011 Sep; 66(9):764-8. PubMed ID: 21474497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term treatment of irbesartan and hydrochlorothiazide decreases plasma N-terminal pro-brain natriuretic peptide levels in subjects with acute exacerbations of COPD.
    Jiang GY; Li Q; Lv YX
    Int J Chron Obstruct Pulmon Dis; 2019; 14():73-80. PubMed ID: 30587963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotyping COPD exacerbations using imaging and blood-based biomarkers.
    Alotaibi NM; Chen V; Hollander Z; Hague CJ; Murphy DT; Leipsic JA; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
    Int J Chron Obstruct Pulmon Dis; 2018; 13():217-229. PubMed ID: 29386890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of nasal intermittent positive pressure ventilation on N-terminal pro-brain natriuretic peptide in patients with acute exacerbations of chronic obstructive pulmonary disease and type II respiratory failure].
    Wang Y; Yang Y; Chen P; Luo Y; Yang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 37(4):325-31. PubMed ID: 22561561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function.
    van Gestel YR; Goei D; Hoeks SE; Sin DD; Flu WJ; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
    COPD; 2010 Feb; 7(1):70-5. PubMed ID: 20214466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure.
    Yao C; Wang L; Shi F; Chen R; Li B; Liu W; Feng M; Li S
    Int J Med Sci; 2021; 18(7):1592-1599. PubMed ID: 33746575
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study.
    Winther JA; Brynildsen J; Høiseth AD; Strand H; Følling I; Christensen G; Nygård S; Røsjø H; Omland T
    Respir Res; 2017 Nov; 18(1):184. PubMed ID: 29100503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction.
    Adrish M; Nannaka VB; Cano EJ; Bajantri B; Diaz-Fuentes G
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1183-1189. PubMed ID: 28458528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma N-terminal pro-brain natriuretic peptide: a prognostic marker in patients with chronic obstructive pulmonary disease.
    Chi SY; Kim EY; Ban HJ; Oh IJ; Kwon YS; Kim KS; Kim YI; Kim YC; Lim SC
    Lung; 2012 Jun; 190(3):271-6. PubMed ID: 22246552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers.
    Abroug F; Ouanes-Besbes L; Nciri N; Sellami N; Addad F; Hamda KB; Amor AB; Najjar MF; Knani J
    Am J Respir Crit Care Med; 2006 Nov; 174(9):990-6. PubMed ID: 16840745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.